نتایج جستجو برای: exemestane

تعداد نتایج: 576  

2015
Jiayu Wang Binghe Xu Peng Yuan Fei Ma Qing Li Pin Zhang Ruigang Cai Ying Fan Yang Luo Qiao Li Ming-hui Wu.

A promising option as the treatment of choice for premenopausal patients with locally advanced or metastatic breast cancer (MBC) could be the combination of a luteinizing hormone-releasing hormone analog and an aromatase inhibitor. However, no prospective studies on the efficacy of goserelin with exemestane in locally advanced or MBC premenopausal breast cancer patients have been reported.We pr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Weimin Li Joyce O'Shaughnessy Daniel Hayes Mario Campone Igor Bondarenko Irina Zbarskaya Etienne Brain Marina Stenina Olga Ivanova Marie-Pascale Graas Patrick Neven Deborah Ricci Thomas Griffin Thian Kheoh Margaret Yu Michael Gormley Jason Martin Michael Schaffer Kathy Zelinsky Peter De Porre Stephen R D Johnston

PURPOSE Abiraterone may suppress androgens that stimulate breast cancer growth. We conducted a biomarker analysis of circulating tumor cells (CTCs), formalin-fixed paraffin-embedded tissues (FFPETs), and serum samples from postmenopausal estrogen receptor (ER)+ breast cancer patients to identify subgroups with differential abiraterone sensitivity. METHODS Patients (randomized 1:1:1) were trea...

2017
Tomas Pascual María Apellániz-Ruiz Cristina Pernaut Cecilia Cueto-Felgueroso Pablo Villalba Carlos Álvarez Luis Manso Lucia Inglada-Pérez Mercedes Robledo Cristina Rodríguez-Antona Eva Ciruelos

PURPOSE Metastatic breast cancer (MBC) progressing after endocrine therapy frequently activates PI3K/AKT/mTOR pathway. The BOLERO-2 trial showed that everolimus-exemestane achieves increased progression free survival (PFS) compared with exemestane. However, there is great inter-patient variability in toxicity and response to exemestane-everolimus treatment. The objective of this study was to pe...

Journal: :International Journal of Applied Pharmaceutics 2022

Objective: A potent aromatase inhibitor, Exemestane, is well known for its anticancer action in breast neoplasm. The vital problem of this medicament poor aqueous solubility, which hinders dissolution body fluids. Therefore, the present study targets to enhance water solubility Exemestane by means complexation with β-cyclodextrin and a suitable ternary agent. Methods: Inclusion complexes agent ...

2010
Alice Dewdney Sarah Needleman

Breast cancer is a significant problem worldwide. Five years of Tamoxifen has been the established endocrine adjuvant therapy for both preand post-menopausal women for several decades, until the more recent introduction of AI’s for use in post-menopausal ER-positive EBC. There are three third generation AI’s currently available commercially these include non steroidal (anastrozole and letrozole...

Journal: :The journal of physical chemistry. B 2016
Ignacio Viciano Sergio Martí

Human aromatase (CYP19A1) aromatizes the androgens to form estrogens via a three-step oxidative process. The estrogens are necessary in humans, mainly in women, because of the role they play in sexual and reproductive development. However, these also are involved in the development and growth of hormone-dependent breast cancer. Therefore, inhibition of the enzyme aromatase, by means of drugs kn...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Mikihiro Kohno Tatsuro Okamoto Kenichi Suda Mototsugu Shimokawa Hirokazu Kitahara Shinichiro Shimamatsu Hideyuki Konishi Tsukihisa Yoshida Mitsuhiro Takenoyama Tokujiro Yano Yoshihiko Maehara

PURPOSE Lung adenocarcinomas among never-smokers are more common in females than in males. This implies that gender-dependent hormones promote smoking unrelated lung adenocarcinoma. We therefore investigated mRNA expression of aromatase, an intrinsic estrogen synthetase, in lung adenocarcinoma and assessed its correlation to clinicopathologic factors, including EGFR mutations and postsurgical p...

Journal: :Therapeutic Advances in Medical Oncology 2012

2017
Muhammad Nuh Musa Sheba Rani David Ihsan Nazurah Zulkipli Abdul Hanif Mahadi Srikumar Chakravarthi Rajan Rajabalaya

Introduction: The use of liquid crystalline (LC) gel formulations for drug delivery has considerably improved the current delivery methods in terms of bioavailability and efficacy. The purpose of this study was to develop and evaluate LC gel formulations to deliver the anti-cancer drug exemestane through transdermal route. Methods: Two LC gel formulations were prepared by phase separation coace...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید